Live feed08:14:00·30dPRReleasevia QuantisnowHungary Approves Trial Expansion as HT-001 Meets Primary Endpoint in Interim Analysis with Patients Reaching ARIGA ≤1 by Week SixByQuantisnow·Wall Street's wire, on your screen.HOTH· Hoth Therapeutics Inc.Health Care
